Curia (formerly AMRI)
Curia (formerly Albany Molecular Research Inc., AMRI) is a global contract research, development and manufacturing organization that provides drug discovery, active pharmaceutical ingredient (API) development, and finished dosage form manufacturing services to pharmaceutical and biotech companies. It supports customers across the full small-molecule lifecycle from early discovery through commercial production, generating revenue through fee-for-service and long-term outsourcing contracts. Curia serves large pharma, emerging biotechs, and generics manufacturers worldwide from a network of R&D centers and manufacturing sites.
- IT Consulting & Implementation
- Revenue
- $1.3B
- Employees
- 3,900
- Founded
- 1991
- Headquarters
- Albany, United States of America
What 9 Arbolus experts think of Curia (formerly AMRI)
NPS scores show a skew towards positive sentiment, with 67% of respondents reporting NPS scores of 8 or higher, and only 11% providing a negative NPS (3). Renewal intent is mixed: 11% intend to renew, 22% are unsure, and 11% do not intend to renew; the rest are undisclosed. Stickiness is high among those implemented for more than one year (67%). Key themes include sustained engagement among high NPS and high spend customers, offset by uncertainties among Influencers and those with NPS in the 6–7 range. Overall Customer Sentiment: Positive
Who reviewed Curia (formerly AMRI)
- C-Suite 33% (3)
- Director 33% (3)
- Manager 33% (3)
Employer names and spend open once the report publishes.
Tell us when the Curia (formerly AMRI) report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
-11 Net Promoter Score, from 9 scored reviews- Promoters 1
- Passives 6
- Detractors 2
Cumulative NPS by month
-1 over 3 months- Jan 8
- Feb 7
- Mar 7
Net Promoter Score across 1 reviews, accumulated up to each month. Category median -11 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 25%Plan to renew, by seniority
- 0% 1 answer
- 50% 2 answers
- 0% 1 answer
- 8/10 Average score from customers who will renew
- 7.5/10 Average score from undecided customers
- 8/10 Average score from customers not renewing
More in Consulting & Professional Services
Other companies in Consulting & Professional Services with a customer report.
For people who use Curia (formerly AMRI)
Do you use Curia (formerly AMRI) at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 9 customers of Curia (formerly AMRI) have already contributed
Takes a few minutes. Your identity stays anonymous.